Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I P Horváth

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Cancer & Clinical Oncology|June 1, 1982
Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivativesI P Horváth, S Somfai-Relle, L Hegedüs, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?S Eckhardt, S Kerpel-Fronius, I P Horváth, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1985
Rat liver-mediated degradation of dibromodulcitolJ Csetényi, E Gáti, L Hegedüs, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1984
A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent Lycurim (ritrosulfan; R-74; NSC-122 402)L Hegedüs, S Kerpel-Fronius, I P Horváth, et al.
European Journal of Cancer|March 1, 1979
Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBDI P Horváth, J Csetényi, S Kerpel-Fronius, et al.
European Journal of Cancer|September 1, 1975
Preliminary pharmacological studies with 1,6-dimesyl-2,3-4,5-dianhydro-L-iditol in patients with cancerJ Csetényi, V Bihari, S I Számel, et al.
Biochemical Pharmacology|January 1, 1975
Dithiazepane formation from reactive bifunctional alkylating agentsA B Foster, A M Gilsenan, I P Horváth, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumourJ Csetényi, D Afra, S Kerpel-Fronius, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1986
Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBDI P Horváth, J Csetényi, S Kerpel-Fronius, et al.
Oncology|January 1, 1980
Chemical reactivity and intracavitary application of alkylating sugar alcohol derivativesS Kerpel-Fronius, J Csetényi, L Hegedüs, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Cancer & Clinical Oncology|June 1, 1982
Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivativesI P Horváth, S Somfai-Relle, L Hegedüs, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?S Eckhardt, S Kerpel-Fronius, I P Horváth, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1985
Rat liver-mediated degradation of dibromodulcitolJ Csetényi, E Gáti, L Hegedüs, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1984
A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent Lycurim (ritrosulfan; R-74; NSC-122 402)L Hegedüs, S Kerpel-Fronius, I P Horváth, et al.
European Journal of Cancer|March 1, 1979
Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBDI P Horváth, J Csetényi, S Kerpel-Fronius, et al.
European Journal of Cancer|September 1, 1975
Preliminary pharmacological studies with 1,6-dimesyl-2,3-4,5-dianhydro-L-iditol in patients with cancerJ Csetényi, V Bihari, S I Számel, et al.
Biochemical Pharmacology|January 1, 1975
Dithiazepane formation from reactive bifunctional alkylating agentsA B Foster, A M Gilsenan, I P Horváth, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumourJ Csetényi, D Afra, S Kerpel-Fronius, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1986
Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBDI P Horváth, J Csetényi, S Kerpel-Fronius, et al.
Oncology|January 1, 1980
Chemical reactivity and intracavitary application of alkylating sugar alcohol derivativesS Kerpel-Fronius, J Csetényi, L Hegedüs, et al.
Pageof 2